Latest news with #ABCHealth
ABC News
04-07-2025
- Politics
- ABC News
A silver lining to US research funding woes
Belinda Smith: Hi, this is The Science Show, and I'm Belinda Smith, keeping Robyn Williams' seat toasty and warm for the next few weeks. Few activities are as satisfying as making something, whether that's baking the perfect pavlova or knocking up a nesting box. But how would you even begin to create, I don't know, a brand new flavor or bring back to life an extinct species of frog? Those stories are coming up but first is the US experiencing a brain drain? News Grab: Good morning. It's now 5.35 here in the east. We are allowing all of our stations across the country to join us. Now with the breaking news, we are projecting at this hour the 47th president of the United States. Uh, Donald Trump will be, uh, elected to return to the White House. Belinda Smith: Since President Donald Trump retook office, the state of scientific research in the States has been well precarious, to say the least. The administration immediately implemented a federal spending freeze, so that included government funded grants and has proposed billions of dollars in cuts to science and health research. Billions with a B. It's just so hard to keep up with all of this, and it's not even been six months. The silver lining is that other countries like Australia are taking advantage of the situation and targeting programs at US researchers. ABC Health reporter, Olivia Willis, has been looking into this and she joins me now. So Liv, what's the latest out of the states when it comes to research funding? Olivia Willis: So since Trump's return to office in January, there's been. As you say, a real frenzy of government funding freezes, cuts, executive orders, all of which have had a major impact on scientific and medical research on national science and health agencies in the us um, but also science and health funding in, in many parts of the world that are reliant on US funding and that includes, uh, researchers in Australia. We know that so far. Well over a thousand research grants have been terminated at government agencies, including the National Institutes of Health, the National Science Foundation, and NASA. Together, those total, several billions of dollars, and there's many more grants that have also been flagged for review. And then on top of that, hundreds of staff have been cut from some of these federal agencies that I mentioned, as well as. The Centers for Disease Control, the FDA and the Trump administration has also targeted specific universities, many of which are Ivy League schools, places like Harvard and Columbia, and frozen their federal funding if they don't comply with a set of demands that the government has laid out. And they're often things related to affirmative action, diversity initiatives, um, campus protests and so on. Big picture for year, the White House budget. Their proposal now is to cut. The National Institutes of Health, their budget by 40%, and the National Science Foundation's budget by 55%. So very, very significant. I will say that thinking broadly about these cuts, the government has said that they're essentially about eliminating waste and bias in government funded research. But I think, you know, they're also the result of efforts to combat what the Trump administration has described as gender, ideology, um, and an executive order to end diversity, equity, and inclusion efforts. So we know that many of the cancel grants or grants under review focus on marginalized and underrepresented groups, uh, racial and ethnic minorities. So groups that have, have been largely understudied historically, and the Trump administration perhaps doesn't see this type of research as benefiting broadly the health of all Americans. Belinda Smith: What other areas of faced cuts? Olivia Willis: There's also research areas that have lost funding simply because they're not priorities of the Trump administration or, or I guess the government doesn't see them as fitting in with their own scientific agenda. So things like research into vaccine misinformation, uh, hiv aids, climate science, clean energy. I should note that this is a really fast moving situation and things will probably change. So we know that a number of lawsuits have been launched against the government regarding these funding freezes and cuts. Some of them have been successful. Just a couple of weeks ago, a federal judge ruled that the cancellation of more than $1 billion in research grants at the National Institutes of Health. That they were illegal in order for them to be reinstated. It looks like the government will file an appeal on that judgment, but in the meantime, staff at at certain agencies have been instructed not to cancel any further grants. So it's definitely a fast moving, unfolding dynamic situation. I. Belinda Smith: And may get dragged through the courts for months and months to come. Olivia Willis: I think so. Belinda Smith: Mm. What have these cuts done to researchers? Olivia Willis: Well, I think it's probably important to think about the context of how significant the US is as a player in research funding globally. So. It's, it's one of the biggest funders in the world of research and development. The National Institutes of Health alone is the biggest funder of medical research globally. A huge number of researchers around the world would benefit off funding from that agency. Um, and in 2023, it was estimated that the US actually provided 30% of all global r and d funding. So you can. Get a sense there from just how much they contribute to what those cuts would mean in terms of specific research fields. There's, you know, we're seeing areas of research, I guess, that have been threatened because huge chunks of their funding have been wiped out. And then for the researchers. The people who work at these federal agencies, a lot of people have lost their jobs, um, or their funding. That of course includes principal investigators and professors, but also early career researchers, PhD students, people who rely on scholarships. And I think the other thing is that for many scientists, it appears to have really created, I guess, a climate of, of fear and worry about their jobs and the viability of their research long term. Belinda Smith: You are listening to Belinda Smith on the Science Show, and I'm talking to health reporter Olivia Willis, about the state of research funding in the United States. Now, I've seen reports of countries that are seeing this as an opportunity for them to really beef up their local scientific expertise and try and get that US talent to relocate to their countries and establish their research programs There. What's been going on in that space and what's Australia's done? Olivia Willis: Yeah, we are, so there's several European universities that have set up initiatives. Um, countries like France and Canada are actively recruiting. The European Commission recently announced 500 million euros to make Europe a magnet for researchers in the next two years. So I suspect that's going to be a popular location for some US scientists when it comes to Australia. There are a number of research institutes. That I know have received really significant interest from US researchers since these cuts have happened. And recruiting scientists is something that the Australian Academy of Science is actively working on. So in April, they set up a program to nationally coordinate this recruitment effort. It's called the Global Talent Attraction Program, and I recently spoke to the academy's chief executive, Anna Maria Arabia, about this. Anna-Maria Arabia: We know that talent is everywhere. Uh, but opportunity is not everywhere. And, uh, this is a, an initiative to attract to Australia leading talent that we know, uh, builds capability in Australia that builds our, uh, scientific talent pool. Um, that enables scientific advancements and industries, um, to be seeded and to grow. Um, importantly, talent like this train and mentor, the next generation of young Australian scientists, uh, we know it creates jobs. Um, and, and we know science and technology is part of a really, um, rapid, uh, global race at the moment. Belinda Smith: So the Australian Academy of Sciences calls this a global talent attraction program, but it sounds quite targeted to the us Olivia Willis: Yeah, that's right. So at least initially it is specifically for US scientists, um, and also Australian scientists in the US who are wanting to return home. As I mentioned, in April, they launched the program and that was about essentially getting funders for it and people to kind of support this research. But it was actually just this week that they've announced that applications for the program are now open. Belinda Smith: So it's early days yet really in terms of getting people involved in the program that might be interested in coming to Australia. Do you know if the Australian Academy of Sciences has any priorities in terms of the, the types of research that they're particularly interested in attracting? Olivia Willis: So the program itself, they've described as discipline agnostic, meaning I think that it, it's not limited to any specific areas of research. That being said, when I spoke to Anna Maria Arabia about it, she told me that one of the reasons they wanted to launch it was so they could assess applications against Australia's. What they call capability gaps. So she talked about areas like data science, statistics, mathematics, um, all being areas that as a kind of research landscape we need to bolster and also touched on issues about the fact that our population is aging, that we need to decarbonize. So it sounds like there will be. Some kind of strategic considerations that are made when they're looking at the types of, um, the, the areas of research that they want to bring more expertise in. Anna-Maria Arabia: We are also looking at areas where there is just outstanding talent that we know if they were to come to Australia, there is no doubt that the multiplier effect and the impact of their contribution, uh, would be many times, uh, what it costs to bring them here. It is the story of Australia. Uh, so many of our leading scientists today were born overseas. We look at our own fellowship, who Australia's most distinguished scientists, and we did account since 2017. Um, the fellows elected to the academy. 42% of them were born overseas. It is the Australian story. Uh, our research effort is relatively young and since World War II and so many of our stellar scientists, you only need to think of Professor Michelle Simmons or Lydia Roka or Brian Schmidt, all born abroad, all bought their capability here as young scientists who, who seeded, uh, talent here, who nurtured the next generation and have now built Um, research sectors and industries we could have only dreamed of. Olivia Willis: So what does this program involve? So once the academy has identified scientists that they're interested in bringing to Australia, they'll work with universities and research institutes to look at. Basically where they can place them so the universities and the research organizations will host them. And my understanding is the Academy's talent attraction program will provide the research funding and the relocation support. Belinda Smith: Mm-hmm. And what about like local researchers? You know, it, it's, it's a, it's a tough old grind being scientists having to apply for grants and. Olivia Willis: Is there any support for local people? It is a great question and it's something I put to her as well. You know, as you say, research funding is extremely competitive in Australia. A lot of researchers miss out, and so I asked whether that was a concern, you know, pouring funding into US scientists or international researchers when many of our own researchers are struggling to get grants. Anna-Maria Arabia: I think we should do everything we can in Australia to nurture young talent, but I feel that these are related, but separate strategies. Uh, so to those young researchers, I would say, uh, through this program we are attracting to Australia, uh, individuals who will inspire you, who will mentor and train you. Um, and provide opportunities that don't exist today. They are not taking away money that would otherwise go to support early career researchers. In fact, they create opportunities for them. Belinda Smith: That was Anna Maria Arabia, CEO of the Australian Academy of Science and ABC Health reporter Olivia Willis, filling us in on the US research funding situation. And now a story of scientific endeavor from our shores. Come with me and let's take a trip back to 2013.
Zawya
06-02-2025
- Business
- Zawya
Medlab Middle East spotlights AI in African diagnostics as the 24th edition of the event concludes
Medlab Middle East concludes today at the Dubai World Trade Centre, having showcased more than 800 exhibitors from over 40 countries The event returns in February 2026 as WHX Labs Dubai Dubai, United Arab Emirates: Amid rapid transformation in Africa's healthcare sector, Medlab Middle East hosted a dedicated session today on ' Doing Business in Africa - Transforming Diagnostic Business Models with AI and other Technologies to Access New Markets '. Led by the African Business Coalition for Health (ABCHealth), the event brought together industry leaders, policymakers and healthcare innovators to explore AI-driven solutions and the technological advancements shaping Africa's diagnostics landscape. With growing healthcare demands and underserved markets, Africa presents significant opportunities for businesses leveraging AI, automation and data-driven solutions. The ABCHealth session highlighted the innovative approaches, key market-entry strategies, and technology-driven collaborations that enable businesses to tap into Africa's dynamic and evolving healthcare ecosystem, fostering sustainable growth and improved health outcomes. During the welcome address, Dr Mories Atok i, CEO, African Business Coalition for Health (ABCHealth), Nigeria said: 'Whether you represent a government body, a private enterprise, or an academic institution, the contributions today matter. Together, we have the opportunity to overcome barriers and harness the power of artificial intelligence and other technologies to transform the diagnostics business models that will define the future of healthcare in the African continent. Today is about maximising the opportunities to exchange ideas, network, connect and inspire one another.' The opening keynote session by Professor Hatem Mostafa ElGabaly, Former Minister of Health, Egypt, highlighted the importance of African countries and the opportunities to support and promote businesses from the country. He said, 'The current state of health diagnostics in Africa is prohibited by the limited access to advanced diagnostic tools. In some regions, there is only one radiologist per 500,000 people. In addition, there is a high disease burden with an inadequate healthcare infrastructure. Africa accounts for 24% of the global disease burden but only 3% of the global health workforce. This underscores the importance of investment, which has the potential to improve health outcomes and economic growth, as well as utilising technology to leapfrog traditional healthcare models.' In addition to the Africa-focused session, Medlab Middle East has hosted two high-level breakfast forums this week, which brought together global and regional laboratory leaders to discuss the key issues shaping the future of diagnostics and healthcare. The Global Lab Leaders Breakfast Forum gathered Medlab portfolio global advisers, scientific chairs, international partners and stakeholders to tackle the global harmonisation of laboratory practices. Discussions at the new forum also explored the critical role of labs in managing global health crises, fostering international collaboration, and shaping the future of laboratory medicine. Themed 'Strengthening cooperation amongst laboratories in the GCC', the GCC Lab Leaders Forum at Medlab Middle East brought together officials, experts and specialists from both public and private sector laboratories and national standardisation bodies across the region. The forum focused on strengthening laboratory networks region-wide, with topics addressed including career pathways for medical laboratory professionals and the formation of a GCC medical lab alliance. Medlab Middle East concludes today having featured over 800 exhibitors from over 40 countries and welcoming an expected attendee count of 20,000 visitors. In addition to the ABCHealth Forum and Leaders' Breakfast Forums, new features this year have included the Women's Health Leadership Forum, Precision Medicine Leadership Forum and the CME-accredited Lab Automation conference track. The event has brought together exhibitors and visitors from more than 180 countries, providing an unrivalled platform to showcase the latest innovations and discover a wide variety of cutting-edge medical laboratory products and services. The key product categories showcased at Medlab Middle East are Disposable, Healthcare/General Services, Imaging, Infrastructure, IT, Laboratory, Medical Equipment and Pharma/Nutrition. Industry leaders featured at the event include Al Borg Diagnostics, Fujifilm Middle East FZE, Horiba ABX SAS, Sysmex Middle East, Randox Laboratories and Snibe. After 24 years of success, Medlab Middle East is evolving into WHX Labs Dubai, uniting with the World Health Expo (WHX) to foster greater global collaboration, innovation and impact in the laboratory industry. WHX Labs Dubai will be joined by city-based events in Lagos, Cape Town, Nairobi, Kuala Lumpur and Bangkok to strengthen relationships and accelerate knowledge sharing. The inaugural WHX Labs Dubai will take place from 9 to 12 February,2026. About Medlab Middle East As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in advancing the value of laboratory medicine worldwide, shaping the future of diagnostics by providing an international platform for laboratory industry leaders, including manufacturers, dealers and distributors to share best practice, showcase innovations, collaborate and network. Medlab Middle East stems from 15 years of growth alongside the MENA region's largest healthcare event, Arab Health. Now in its 24th year, this annual medical laboratory meeting brings together exhibitors and attendees from over 180 countries. Medlab Middle East will take place from 3 – 6 February 2025 at the Dubai World Trade Centre, Dubai, UAE. A digital event will occur from 4 December – 20 February 2025. Website: Facebook: Twitter: @MedlabSeries #myMedlab Instagram: @ LinkedIn: Medlab Middle East For more information, please get in touch with Shamal Communications: Media Contact CATHERINE ALLTOFT ACCOUNT DIRECTOR E-mail :
Al Bawaba
06-02-2025
- Health
- Al Bawaba
Medlab Middle East spotlights AI in African diagnostics as the 24th edition of the event concludes
Amid rapid transformation in Africa's healthcare sector, Medlab Middle East hosted a dedicated session today on 'Doing Business in Africa - Transforming Diagnostic Business Models with AI and other Technologies to Access New Markets'. Led by the African Business Coalition for Health (ABCHealth), the event brought together industry leaders, policymakers and healthcare innovators to explore AI-driven solutions and the technological advancements shaping Africa's diagnostics landscape. With growing healthcare demands and underserved markets, Africa presents significant opportunities for businesses leveraging AI, automation and data-driven solutions. The ABCHealth session highlighted the innovative approaches, key market-entry strategies, and technology-driven collaborations that enable businesses to tap into Africa's dynamic and evolving healthcare ecosystem, fostering sustainable growth and improved health outcomes. During the welcome address, Dr Mories Atoki, CEO, African Business Coalition for Health (ABCHealth), Nigeria said: 'Whether you represent a government body, a private enterprise, or an academic institution, the contributions today matter. Together, we have the opportunity to overcome barriers and harness the power of artificial intelligence and other technologies to transform the diagnostics business models that will define the future of healthcare in the African continent. Today is about maximising the opportunities to exchange ideas, network, connect and inspire one another.' The opening keynote session by Professor Hatem Mostafa ElGabaly, Former Minister of Health, Egypt, highlighted the importance of African countries and the opportunities to support and promote businesses from the country. He said, 'The current state of health diagnostics in Africa is prohibited by the limited access to advanced diagnostic tools. In some regions, there is only one radiologist per 500,000 people. In addition, there is a high disease burden with an inadequate healthcare infrastructure. Africa accounts for 24% of the global disease burden but only 3% of the global health workforce. This underscores the importance of investment, which has the potential to improve health outcomes and economic growth, as well as utilising technology to leapfrog traditional healthcare models.' In addition to the Africa-focused session, Medlab Middle East has hosted two high-level breakfast forums this week, which brought together global and regional laboratory leaders to discuss the key issues shaping the future of diagnostics and healthcare. The Global Lab Leaders Breakfast Forum gathered Medlab portfolio global advisers, scientific chairs, international partners and stakeholders to tackle the global harmonisation of laboratory practices. Discussions at the new forum also explored the critical role of labs in managing global health crises, fostering international collaboration, and shaping the future of laboratory medicine. Themed 'Strengthening cooperation amongst laboratories in the GCC', the GCC Lab Leaders Forum at Medlab Middle East brought together officials, experts and specialists from both public and private sector laboratories and national standardisation bodies across the region. The forum focused on strengthening laboratory networks region-wide, with topics addressed including career pathways for medical laboratory professionals and the formation of a GCC medical lab alliance. Medlab Middle East concludes today having featured over 800 exhibitors from over 40 countries and welcoming an expected attendee count of 20,000 visitors. In addition to the ABCHealth Forum and Leaders' Breakfast Forums, new features this year have included the Women's Health Leadership Forum, Precision Medicine Leadership Forum and the CME-accredited Lab Automation conference track. The event has brought together exhibitors and visitors from more than 180 countries, providing an unrivalled platform to showcase the latest innovations and discover a wide variety of cutting-edge medical laboratory products and services. The key product categories showcased at Medlab Middle East are Disposable, Healthcare/General Services, Imaging, Infrastructure, IT, Laboratory, Medical Equipment and Pharma/Nutrition. Industry leaders featured at the event include Al Borg Diagnostics, Fujifilm Middle East FZE, Horiba ABX SAS, Sysmex Middle East, Randox Laboratories and Snibe. After 24 years of success, Medlab Middle East is evolving into WHX Labs Dubai, uniting with the World Health Expo (WHX) to foster greater global collaboration, innovation and impact in the laboratory industry. WHX Labs Dubai will be joined by city-based events in Lagos, Cape Town, Nairobi, Kuala Lumpur and Bangkok to strengthen relationships and accelerate knowledge sharing. The inaugural WHX Labs Dubai will take place from 9 to 12 February,2026. © 2000 - 2025 Al Bawaba (
